ArticleFrontiers in oral health2026
Prediction of loss of heterozygosity in oral cavity dysplasia through vascular pattern.
Article in Frontiers in oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04504552 (Phase II Trial, Open Label, Single-arm, of Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Phase II Trial, Open Label, Single-arm, of Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Loss of Heterozygosity (LOH) is a key genetic alteration associated with progression of oral cavity dysplasia to oral squamous cell carcinoma, yet non-invasive methods to predict LOH status are lacking. The aim of this study is to investigate whether vascular pattern abnormalities detected through Narrow Band Imaging (NBI) can predict LOH status in oral dysplasia using machine learning-based quantitative analysis. Methods: This was a retrospective analysis of prospectively collected data from the IMPEDE multicenter clinical trial (NCT04504552). The study sample included 31 patients with oral potentially malignant disorders (13 LOH-positive, 18 LOH-negative) and 125 region-of-interest (ROI) images. Predictor variables were quantitative vascular morphology features: vessel length, number of intersections, tortuosity, branching angles, fractal dimensions, which were extracted from NBI images using the Jerman Vesselness Filter and pvbm library. Main outcome variable was LOH status (positive Results: Of 31 patients (median age 65 years; 19 males, 12 females), 13 (42%) were LOH-positive. Significant differences in vascular morphology were observed between LOH-positive and LOH-negative samples. The SVM classifier achieved a patient-level accuracy of 77.4% (24/31 correctly classified), with an area under the ROC curve (AUC) of 0.75. Conclusions: Non-invasive quantitative vascular pattern analysis from NBI images demonstrates good discriminative ability for predicting LOH status in oral dysplasia. This approach has potential as an adjunct diagnostic tool for early cancer risk stratification, potentially reducing the need for invasive biopsies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.